skip to Main Content
enquiries@thearmchairtrader.com

Sign up for our Free Daily Digest newsletter: Actionable insight every morning, designed for the self-directed investor. Find out more

Three things you need to know in the financial markets this morning from investment writer, Tony Cross.

Greggs

There’s a trading update out from Greggs [LON:GRG] this morning as the company continues to recover from the COVID lockdown. Sales for the 4 weeks to September 26th were 76% of those seen a year earlier, in line with the previously made assumptions. The company has reactivated elements of its new store opening plans but acknowledges that with demand set to remain subdued for the foreseeable future, it needs to reduce staffing costs. The aim is to avoid outright redundancies but this will be a tough call and an update on the financial implications here will be provided in November. The company adds that the outlook for trading remains uncertain.

Synairgen

Interim numbers from Synairgen [LON:SNG], the company which saw a bumper performance in the summer after its successful trails for a COVID therapy. Details beyond this however appear scant – they are in discussions with regulators over the approval route for the COVID therapy and are investing in the supply chain to ensure that should approval be granted, they can meet potential demand. The question is whether investors will have expected more from this note.


B&M European Value Retail

There’s a first half trading update out from discount retailer B&M [LON:BME] this morning, covering the period to September 26th. Group revenues have accelerated by more than 25%, driven by an increase in average spend per visit. The company is expanding its footprint, having opened 9 larger stores and closed 8 smaller ones during the period.  Again detail beyond this is scant, but it’s difficult not to see the format as being a winner in an increasingly fraught physical retail market.

Sign up for three quick facts and more with our Free Daily Digest newsletter, every weekday morning.

Please note this article does not constitute investment advice. Investors are encouraged to do their own research beforehand or consult a professional advisor.

Tony Cross

Tony Cross

Tony Cross is a market commentator with over 15 years of experience, producing compelling, insightful copy for journalists and investors alike. Focusing on macroeconomics, UK blue chip equities and inter market analysis, Cross's commentary is well regarded for its clarity and ability to cut through the waffle. He has been quoted in publications as diverse as The Financial Times, The Times, The Guardian and The Sun. He has also been a regular guest on both Share Radio and TipTV.

Comments

Back To Top